A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
Clinical trial NCT07173556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07173556
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-02-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.